JP2002513392A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513392A5 JP2002513392A5 JP1998524895A JP52489598A JP2002513392A5 JP 2002513392 A5 JP2002513392 A5 JP 2002513392A5 JP 1998524895 A JP1998524895 A JP 1998524895A JP 52489598 A JP52489598 A JP 52489598A JP 2002513392 A5 JP2002513392 A5 JP 2002513392A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3174196P | 1996-11-25 | 1996-11-25 | |
| US60/031,741 | 1996-11-25 | ||
| US96760697A | 1997-11-10 | 1997-11-10 | |
| US08/967,606 | 1997-11-10 | ||
| PCT/US1997/022016 WO1998023263A1 (en) | 1996-11-25 | 1997-11-12 | Ascending-dose dosage form |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010099006A Division JP5215347B2 (ja) | 1996-11-25 | 2010-04-22 | 上昇する投与量の薬剤投与型 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002513392A JP2002513392A (ja) | 2002-05-08 |
| JP2002513392A5 true JP2002513392A5 (enExample) | 2005-08-11 |
| JP5173089B2 JP5173089B2 (ja) | 2013-03-27 |
Family
ID=26707551
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52489598A Expired - Lifetime JP5173089B2 (ja) | 1996-11-25 | 1997-11-12 | 上昇する投与量の薬剤投与型 |
| JP2010099006A Expired - Lifetime JP5215347B2 (ja) | 1996-11-25 | 2010-04-22 | 上昇する投与量の薬剤投与型 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010099006A Expired - Lifetime JP5215347B2 (ja) | 1996-11-25 | 2010-04-22 | 上昇する投与量の薬剤投与型 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0946151B1 (enExample) |
| JP (2) | JP5173089B2 (enExample) |
| CN (2) | CN100477986C (enExample) |
| AT (1) | ATE325606T1 (enExample) |
| AU (1) | AU5267698A (enExample) |
| CA (1) | CA2265668C (enExample) |
| DE (1) | DE69735848T2 (enExample) |
| DK (1) | DK0946151T3 (enExample) |
| ES (1) | ES2264173T3 (enExample) |
| PT (1) | PT946151E (enExample) |
| WO (1) | WO1998023263A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| US6486177B2 (en) | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| US5922736A (en) | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
| US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US6962997B1 (en) | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
| KR100827254B1 (ko) | 1998-06-03 | 2008-05-07 | 알자 코포레이션 | 연장된 약물 치료를 제공하기 위한 방법 및 장치 |
| US6673367B1 (en) | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
| US6419960B1 (en) | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| US7083808B2 (en) | 1998-12-17 | 2006-08-01 | Euro-Celtique S.A. | Controlled/modified release oral methylphenidate formulations |
| US6395752B1 (en) * | 1999-03-04 | 2002-05-28 | Pharmaquest Limited | Method of treating depression using 1-threo-methylphenidate |
| US6127385A (en) * | 1999-03-04 | 2000-10-03 | Pharmaquest Limited | Method of treating depression using l-threo-methylphenidate |
| IL159715A0 (en) | 2001-07-10 | 2004-06-20 | Teva Pharma | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| NZ552514A (en) | 2001-12-24 | 2008-08-29 | Teva Pharma | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| US7988993B2 (en) | 2002-12-09 | 2011-08-02 | Andrx Pharmaceuticals, Inc. | Oral controlled release dosage form |
| AU2004275835B2 (en) * | 2003-09-26 | 2011-06-23 | Alza Corporation | Controlled release formulations exhibiting an ascending rate of release |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| PL116330U1 (en) | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
| US20100151020A1 (en) | 2008-12-16 | 2010-06-17 | Vered Rosenberger | Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate |
| US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
| MX2021000431A (es) | 2011-03-23 | 2022-10-28 | Ironshore Pharmaceuticals & Dev Inc | Metodos y composiciones para el tratamiento de trastorno por deficit de atencion. |
| CA2936746C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
| CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
| US5024843A (en) * | 1989-09-05 | 1991-06-18 | Alza Corporation | Oral hypoglycemic glipizide granulation |
| ES2064117T3 (es) * | 1990-07-23 | 1995-01-16 | Alza Corp | Dispositivo osmotico oral para el suministro de nicotina. |
| US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
| US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
| DE69229881T2 (de) * | 1991-10-04 | 1999-12-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Tablette mit verzögerter freisetzung |
| US5532003A (en) * | 1994-01-18 | 1996-07-02 | Alza Corporation | Pentoxifylline therapy |
| ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
| US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
| US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
| CN100484518C (zh) * | 1996-08-16 | 2009-05-06 | 阿尔萨公司 | 药物剂量逐渐增加的剂型 |
-
1997
- 1997-11-12 CN CNB2004100929372A patent/CN100477986C/zh not_active Expired - Lifetime
- 1997-11-12 EP EP97947642A patent/EP0946151B1/en not_active Expired - Lifetime
- 1997-11-12 DE DE69735848T patent/DE69735848T2/de not_active Expired - Lifetime
- 1997-11-12 CA CA002265668A patent/CA2265668C/en not_active Expired - Lifetime
- 1997-11-12 WO PCT/US1997/022016 patent/WO1998023263A1/en not_active Ceased
- 1997-11-12 ES ES97947642T patent/ES2264173T3/es not_active Expired - Lifetime
- 1997-11-12 CN CNB97199014XA patent/CN1182839C/zh not_active Expired - Lifetime
- 1997-11-12 AU AU52676/98A patent/AU5267698A/en not_active Abandoned
- 1997-11-12 PT PT97947642T patent/PT946151E/pt unknown
- 1997-11-12 DK DK97947642T patent/DK0946151T3/da active
- 1997-11-12 AT AT97947642T patent/ATE325606T1/de active
- 1997-11-12 JP JP52489598A patent/JP5173089B2/ja not_active Expired - Lifetime
-
2010
- 2010-04-22 JP JP2010099006A patent/JP5215347B2/ja not_active Expired - Lifetime